Nordion
http://www.nordion.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Nordion
Finance Watch: $1.32bn In New Biopharma VC Financings As Year-End Approaches
Private Company Edition: In recent weeks, 19 companies disclosed venture capital funding of $20m or more, including FogPharma with a $178m series D round and Apogee’s $169m launch. Also, Avalon BioVentures spun out of Avalon Ventures with a $135m fund.
Elypta Drops Data Showing Power Of Metabolite-Based MCED Test
Elypta’s MIRAM kit for multi-cancer early detection performed well in a large-scale study.
MorphoSys Teams Up Again With Novartis For Preclinical Cancer Program
The German biotech announced in March that it was terminating the early-stage oncology R&D projects that came with its purchase of Constellation last year and Novartis has snapped up one of them.
ObsEva Stays Afloat By Selling Lead Women’s Health Asset To XOMA
The Swiss firm has divested yet another one of its key programs in a bid to stave off insolvency and remain a listed company, forcing it to focus solely on a pre-IVF drug candidate.
Company Information
- Industry
- Medical Devices
- Other Names / Subsidiaries
-
- MDS Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice